This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Riken Genomic Sciences Center | |
|---|---|
| Name | Riken Genomic Sciences Center |
| Established | 2006 |
| Location | Wako, Saitama, Japan |
| Affiliation | RIKEN |
Riken Genomic Sciences Center
The Riken Genomic Sciences Center was established as a major research institute within RIKEN to advance large-scale genomics research, integrating technologies from bioinformatics, systems biology, and molecular biology to study genomes across species. The center built interdisciplinary teams drawing researchers from institutions such as University of Tokyo, Kyoto University, Osaka University, and international partners including Broad Institute, Max Planck Society, and Wellcome Trust Sanger Institute to pursue high-throughput sequencing, computational analysis, and translational applications.
Founded in 2006 as part of a reorganization of RIKEN research clusters, the center emerged during a period marked by initiatives like the Human Genome Project, the rise of Next-Generation Sequencing technologies, and national science policies influenced by the Fourth Science and Technology Basic Plan (Japan). Early milestones included collaborations with the International HapMap Project teams, joint programs with National Institutes of Health groups, and participation in consortia alongside European Molecular Biology Laboratory and the Jackson Laboratory. Leadership transitions involved scientists trained at institutions such as Harvard University, Stanford University, University of California, Berkeley, and Imperial College London.
Research programs span comparative genomics involving species studied at Zoological Society of London collections, epigenomics with links to projects at European Bioinformatics Institute, and transcriptomics coordinated with Cold Spring Harbor Laboratory groups. Computational genomics initiatives draw methods from teams at Carnegie Mellon University, Massachusetts Institute of Technology, and ETH Zurich, while functional genomics efforts connect to work at NIH National Human Genome Research Institute and Salk Institute for Biological Studies. Applied research targets agricultural genomics engaging National Agriculture and Food Research Organization and biomedical genomics with translational ties to Tokyo University Hospital and Keio University School of Medicine.
Facilities included high-throughput sequencing platforms comparable to arrays used at Broad Institute and computing clusters modeled after infrastructure at Lawrence Berkeley National Laboratory. Laboratories were equipped for single-cell analysis techniques pioneered at MIT Broad Institute Single Cell groups and for CRISPR workflows similar to protocols developed at Broad Institute of MIT and Harvard. The center maintained biorepositories and model organism facilities referencing standards from Jackson Laboratory and imaging suites compatible with systems used at Max Planck Institute for Molecular Cell Biology and Genetics.
The center formed strategic partnerships with international consortia such as 1000 Genomes Project, Earth BioGenome Project, and regional initiatives including Asia-Pacific Advanced Network. Industry collaborations involved biotechnology companies like Illumina, Thermo Fisher Scientific, and pharmaceutical partners analogous to Takeda Pharmaceutical Company and Astellas Pharma. Academic exchange programs tied researchers to University of Cambridge, Columbia University, Peking University, and National University of Singapore.
Organizational units reflected multidisciplinary labs with principal investigators recruited from organizations such as RIKEN Center for Developmental Biology, RIKEN Center for Integrative Medical Sciences, and university departments at Osaka City University. Administrative oversight linked to executive offices influenced by frameworks at Japan Science and Technology Agency and coordination with Ministry of Education, Culture, Sports, Science and Technology (Japan). Training programs paralleled graduate collaborations with Tohoku University Graduate School and postdoctoral fellowships modeled on schemes from European Molecular Biology Organization.
Notable projects included population genomics studies echoing aims of Human Genome Diversity Project, pathogen genomics work related to research at Centers for Disease Control and Prevention and vaccine-relevant efforts similar to those at Wellcome Sanger Institute. Contributions spanned algorithm development inspired by methods from University of California, San Diego bioinformatics groups, reference genome assemblies comparable to outputs from Ensembl and datasets deposited in repositories aligned with DNA Data Bank of Japan. The center's work influenced policy discussions involving G7 Science Ministers meetings and international data-sharing frameworks such as those advocated by Global Alliance for Genomics and Health.
Funding sources combined national appropriation mechanisms overseen by Ministry of Finance (Japan) and competitive grants from agencies including Japan Society for the Promotion of Science, project contracts with corporations like Sony-linked ventures, and international grants from entities such as Wellcome Trust and European Commission. Governance structures included scientific advisory boards with members drawn from National Academy of Sciences (United States), Royal Society, and leadership figures with appointments at institutions such as Keio University and University of Tokyo.
Category:Research institutes in Japan Category:Genomics